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Objectives: The aim of this study was to characterize a collection of 95
Shigatoxin-producing E.coli (STEC) isolated from human patients in Switzerland during
2010–2014.
Methods: We performed O and H serotyping and molecular subtyping.
Results: The five most common serogroups were O157, O145, O26, O103, and
O146. Of the 95 strains, 35 (36.8%) carried stx1 genes only, 43 strains (45.2%) carried
stx2 and 17 (17.9%) harbored combinations of stx1 and stx2 genes. Stx1a (42 strains)
and stx2a (32 strains) were the most frequently detected stx subtypes. Genes for
intimin (eae), hemolysin (hly), iron-regulated adhesion (iha), and the subtilase cytotoxin
subtypes subAB1, subAB2-1, subAB2-2, or subAB2-3 were detected in 70.5, 83.2,
74.7, and 20% of the strains, respectively. Multilocus sequence typing assigned the
majority (58.9%) of the isolates to five different clonal complexes (CC), 11, 32, 29,
20, and 165, respectively. CC11 included all O157:[H7] and O55:[H7] isolates. CC32
comprised O145:[H28] isolates, and O145:[H25] belonged to sequence type (ST) 342.
CC29 contained isolates of the O26:[H11], O111:[H8] and O118:[Hnt] serogroups, and
CC20 encompassed isolates of O51:H49/[Hnt] and O103:[H2]. CC165 included isolates
typed O80:[H2]-ST301, all harboring stx2d, eae-ξ, hly, and 66.7% additionally harboring
iha. All O80:[H2]-ST301 strains harbored at least 7 genes carried by pS88, a plasmid
associated with extraintestinal virulence. Compared to data from Switzerland from the
years 2000–2009, an increase of the proportion of non-O157 STEC infections was
observed as well as an increase of infections due to STEC O146. By contrast, the
prevalence of the highly virulent German clone STEC O26:[H11]-ST29 decreased from
11.3% during 2000–2009 to 1.1% for the time span 2010–2014. The detection of
O80:[H2]-ST301 harboring stx2d, eae-ξ, hly, iha, and pS88 related genes suggests an
ongoing emergence in Switzerland of an unusual, highly pathogenic STEC serotype.
Fierz et al. STEC, Molecular Subtyping, Virulence, and MLST
Conclusions: Serotyping and molecular subtyping of clinical STEC demonstrate that
although STEC O157 predominates among STEC isolated from diseased humans,
non-O157 STEC infections are increasing in Switzerland, including those due to STEC
O146:[H2/H21/H28]-ST442/ST738 harboring subAB variants, and the recently emerged
STEC O80:[H2]-ST301 harboring eae-ξ and pS88 associated extraintestinal pathogenic
virulence genes.
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INTRODUCTION
Shiga toxin (Stx)-producing Escherichia coli (STEC) are
important foodborne pathogens and responsible for outbreaks
and sporadic cases of gastrointestinal illnesses which may
include nonbloody or bloody diarrhea, hemorrhagic colitis
(HC), and the hemolytic uremic syndrome (HUS) (Karch et al.,
2005). Human pathogenic STEC produce one or more Stx,
which consist of two groups designated Stx1 (consisting of the
three variants Stx1a, Stx1c and Stx1d) and Stx2 (composed of
seven distinct variants Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f,
and Stx2g). Among these variants, Stx2a, Stx2c, and Stx2d are
associated with severe disease and Stx2b and Stx2e are linked
to mild clinical symptoms or asymptomatic fecal carriage
(Stephan and Hoelzle, 2000; Friedrich et al., 2002; Fuller et al.,
2011).
Furthermore, STEC strains may feature additional virulence
traits that influence their pathogenic potential, such as intimin,
enterohemolysin, adhesin, and subtilase cytotoxin (SubAB),
which are encoded by eae, hlyA, iha, and subAB genes,
respectively (Paton et al., 2004; Johnson et al., 2006; Käppeli
et al., 2011a). E. coli O157:H7 is the serotype most frequently
associated with outbreaks and severe clinical outcomes and is
to date reported as the most common STEC serotype in the
European Union and in Switzerland (Käppeli et al., 2011b; EFSA,
2016). However, non-O157 STEC serogroups, in particular, O26,
O103, O111, and O145, are also recognized for their pathogenic
potential and constitute together with O157 the so called “top
five” serogroups of human pathogenic STEC in the EU (Beutin,
2006; Johnson et al., 2006; EFSA, 2016). Beside this group of
five, other STEC serogroups, such as O91 and O121 have been
associated with human illness in Germany and Switzerland,
respectively (Mellmann et al., 2009; Käppeli et al., 2011a), and
O45 and O121 are among the top seven serogroups detected in
the U.S.A. (Gould et al., 2013). Changes in the Stx or serotype
distribution of STEC infection is of public health significance
as it may indicate the introduction of increasingly dominant
strains. Identification of such strains is important as it may
predict epidemiological changes or indicate novel sources of
infection.
The aim of the present study was therefore to characterize
all STEC strains collected by the Swiss National Centre
for Enteropathogenic Bacteria and Listeria (NENT, Zurich,
Switzerland) during 2010–2014 and compare these results with
earlier data from Switzerland investigated over the 10-year period
2000–2009 (Käppeli et al., 2011a,b).
MATERIALS AND METHODS
Strain Collection
A total of 95 Shigatoxin-producing Escherichia coli (STEC)
strains isolated from human patients during 2010–2014 in
Switzerland were characterized. The strain collection was
obtained from the Swiss National Centre for Enteropathogenic
Bacteria and Listeria (NENT). Forty-eight strains (50.5%) were
from female and 47 strains (49.5%) from male patients. The
median age was 24 years (range < 1–79 years). Forty-one
strains (43.2%) were isolated from patients ≤ 5 years of age.
The strains had all been confirmed to possess stx genes (stx1
and/or stx2) by real-time PCR (LightCycler R© 2.0 Instrument,
Roche Diagnostics Corporation, Indianapolis, IN, USA), (EURL,
2013a).
Serotyping
Strains were examined by PCR for the presence of genes
associated with 15 selected serogroups including the top-
five serogroups, namely O26, O45, O51, O55, O80, O91,
O103, O104, O111, O113, O121, O128, O145, O146, and
O157 (Perelle et al., 2004; EURL, 2013a,b, 2014; Soysal et al.,
2016).
Strains belonging to other O groups were serotyped at
the National Reference Laboratory for Escherichia coli, Federal
Institute for Risk Assessment, Berlin, Germany, using standard
methods and O–specific rabbit antisera. H types were determined
by PCR, except for O51:H49, which had been typed previously
using standard methods (Fasel et al., 2014). Strains were
tested for the presence of flagellar genes related to H2,
H4, H7, H8, H10, H11, H19, H21, H25, and H28 (Mora
et al., 2012; EURL, 2013b; Beutin et al., 2015; Alonso et al.,
2017).
Virulence Factor Genes
The determination of stx1 subtypes (stx1a, stx1c, stx1d) and stx2
subtypes (stx2a, stx2b, stx2c, stx2d, stx2e, stx2f, and stx2g) was
performed by conventional PCR amplification (Scheutz et al.,
2012). Furthermore, the strains were screened by conventional
PCR for hlyA (Schmidt et al., 1995), iha (Schmidt et al., 2001), and
subAB (encoding SubAB), including its subAB subtypes (subAB1,
subAB2-1, subAB2-2, and subAB2-3), as described previously
(Tozzoli et al., 2010; Funk et al., 2013; Nüesch-Inderbinen
et al., 2015; Müller et al., 2016; Tasara et al., 2017), using
primers listed in Supplementary Table 1. Screening for eae, aggR
coding for a transcriptional regulator in enteroaggregative E. coli
(EAEC), and elt and estIa/Ib encoding heat-labile and heat stabile
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enterotoxins in enterotoxigenic E. coli (ETEC) was performed
by real-time PCR according to the guidelines of the European
Union Reference laboratory (European Union Reference (EURL,
2013c). Identification of the eae variants α1, α2, β1, γ1, γ2/θ, ε1, ζ,
η, ι1, λ, and ξ was performed using primers described by Blanco
et al. (2005).
Strains belonging to O80:H2 were screened by PCR for the
pS88 related genes sitA, cia, iss, iucC, iroN, hlyF, etsC, cvaA, and
ompTp, using primers described by Peigne et al. (2009).
Further Characterization of E. coli O157
Strains
The collection of E. coli O157 strains was tested for sorbitol
fermentation by using sorbitol MacConkey agar (SMAC) (Oxoid
Ltd., Basingstoke, UK). All the E. coliO157 strains were analyzed
by PCR for their flagellar (fliC) genotypes for fliCH7 as described
previously (Gannon et al., 1997). The presence of O157 and
the H7 antigen was corroborated with a latex agglutination test
(WellcolexTME. coli O157:H7, Remel, USA).
Multilocus Sequence Typing (MLST)
MLST was performed by PCR amplification and sequencing of
internal fragments of seven housekeeping genes (adk, fumC,
gyrB, icdF, mdh, purA, and recA) (Wirth et al., 2006). Alleles
and sequence types (STs) were assigned in accordance with the
E. coli MLST database website (http://mlst.warwick.ac.uk/mlst/
mlst/dbs/Ecoli).
RESULTS
Identification of Serotypes
Of the 95 STEC isolates, 78 (82.1%) were assigned to O types by
PCR. Seventeen (17.9%) of the isolates did not fall into any of the
serogroups tested for by PCR. Serological typing classified these
strains into serogroups O46, O75, O76, O78, O80, O82, O84,
O118, O156, O165, O166, O174, O177, O178, O183, ONT, and
O rough. An overview of the determined serotypes is given in
Table 1.
Among the 95 isolates, 18 (19%) were O157:[H7], and 77
(81%) were non-O157 STEC isolates. Of the non-O157 strains,
O145:[H25/H28] was the most common (n = 12/15.6% of
all non-O157 isolates), followed by O26:[H11] (n = 10/13%),
O103:[H2] (n = 10/13%), and O146:[H2/H21/H28] (n =
8/10.4%).
Detection of Virulence Genes
Of the 95 STEC strains, 35 (36.8%) carried stx1 genes only: stx1a
(n = 28) and stx1c (n = 7). Forty-three strains (45.2%) carried
stx2 genes only: stx2a (n= 18), stx2b (n= 7), stx2c (n= 4), stx2d
(n = 6), stx2e (n = 1), and stx2a/stx2c (n = 7). Seventeen strains
(18%) harbored combinations of stx1 and stx2 genes. Forty-eight
strains (50.5% of all isolates) carried the subtypes associated with
high pathogenic potency, stx2a, stx2c, or stx2d (Table 1). The
majority thereof (n= 29/60.4% of the 48 strains) belonged to the
top-five serogroups, predominantly to O157 (n = 17) and O145
(n= 11), but notably, six (12.5%) belonged to serogroup O80.
Twelve isolates harbored the low pathogenic subtypes stx2b
and stx2e and were mainly associated to the serogroups O146
(n= 6/50% of the 12 isolates), as shown in Table 1. None of the
isolates harbored stx2f.
Genes for intimin, enterohemolysin, iron-regulated adhesion
and subtilase cytotoxin were detected in 67 strains (70.5% of all
isolates), 79 strains (83.2%), 71 strains (74.7%), and 19 strains
(20%), respectively. The majority of the subAB harboring isolates
(n= 11/57.9%) was associated with stx2b (Table 1).
The 67 eae positive isolates comprised six intimin variants
including β1 (n= 14/20.9% of the 67 isolates), γ1 (n= 31/46.3%),
and ε1 (n = 12/17.9%), ξ (n = 6/9%), ζ (n = 2/3%), γ2/θ
(n= 1/1.5%) and one (1.5%) non-typeable (nt) strain (Table 1).
Of the six O80:[H2]-ξ strains, all (100%) carried pS88-related
genes sitA, cia, iss, iroN, hlyF, cvaA, and ompTp, and five (83.3%)
additionally had the iucC and the etsC genes (data not shown).
All 95 STEC strains were negative for aggR, elt and estIa/Ib.
Further Characterization of the
O157-Positive Strains
Sixteen (88.9% of all O157-positive isolates) were non-sorbitol
fermenters (nSF) on SMAC. Thereof, 11 were O157:H7 by latex
agglutination. Two strains (11.1%) fermented sorbitol (SF), both
were O157:H- by latex agglutination. However, all 18 strains
tested positive for fliCH7 by PCR (Table 1).
Multilocus Sequence Typing
An overview of the sequence types of the isolates is given in
Table 1.
MLST assigned the majority (58.9%) of the isolates to 5
different clonal complexes (CC): CC11 (n = 19), CC20 (n = 12),
CC29 (n= 12), CC32 (n= 7), and CC165 (n= 6).
Isolates of O serogroup O157 and O55 clustered in CC11.
Isolates of O103 belonged to ST17 or ST386 and were all found
with O51, within CC20. Isolates of the serogroups O26 (ST21
and ST29), O111 (ST16) andO118 (ST21) clustered within CC29.
Seven of the 12 O145 isolates clustered in CC32, whereas further
five O145 isolates belonged to ST342 and were not assigned to
any CC. The isolates of serogroup O80 belonged to ST301 and
CC165.
DISCUSSION
This study describes the serotypes, virulence genes and
multilocus sequence types of STEC associated with human
disease in Switzerland during 2010 and 2014. The five
most common serogroups were O157, O145, O26, O103,
and O146, with E. coli O157 accounting for 19% of the
STEC-related infections. By comparison, during 2000 and
2009, 30.6% of the STEC strains isolated from clinical
cases in Switzerland were STEC O157 (Käppeli et al.,
2011b). Thus, as reported for other countries in the
EU (ECDC, 2015), the proportion of non-O157 STEC
associated with human STEC infections has increased also
in Switzerland.
We further observed a change with regard to the most
common non-O157 serotypes reported for the time span of
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TABLE 1 | Characteristics of 95 STEC strains isolated from human patients from 2010 to 2014 in Switzerland.
Serotypea No. of
strains
stx1 stx2 eae hlyA iha subAB aggR elt,
estIa/Ib
ST CC
O26:[H11] 9 stx1a – β1 + + – – – 21 29
O26:[H11] 1 stx1a stx2a β1 + + – – – 29 29
O46:[Hnt] 1 stx1a stx2c – + + – – – 154 –
O51:[Hnt] 1 – stx2a β1 – – – – – 20 20
O51:H49 1 – stx2e β1 – – – – 20 20
O55:[H7] 1 – stx2a γ1 – – – – 335 11
O75:[H25] 1 stx1a stx2a/stx2d – + + – – – 3249 –
O76:[H19] 1 stx1c stx2b – + + subAB2-1/
subAB2-2
– – 675 –
O78:[H7] 1 stx1c – – + + subAB2-1/
subAB2-2
– – 3101 –
O80:[H2] 1 – stx2a ξ + + – – – 301 165
O80:[H2] 2 – stx2d ξ + − – – – 301 165
O80:[H2] 3 – stx2d ξ + + – – – 301 165
O82:[Hnt] 1 stx1a stx2c – + + subAB1 – – 101 101
O84:[H2] 1 stx1a – ζ + + – – – 306 –
O91:[H14] 1 stx1a – – + + – – – 33 –
O91:[H14] 1 stx1a stx2b – – + subAB2-1/
subAB2-2
– – 33 –
O91:[H10] 1 – stx2d – − + – – – 641 86
O103:[H2] 9 stx1a – ε1 + − – – – 17 20
O103:[H2] 1 stx1a – ε1 + + – – – 386 20
O111:[H8] 1 stx1a – γ2/θ + + – – – 16 29
O113:[H4] 1 stx1c stx2b – + + subAB2-1/
subAB2-2
– – 10 10
O113:[H4] 1 stx2b – + + subAB2-1/
subAB2-2
– – 10 10
O118:[Hnt] 1 stx1a – β1 + + – – – 21 29
O121:[H19] 1 – stx2a ε1 + − – – – 655 –
O145:[H28] 7 – stx2a γ1 + + – – – 32 32
O145:[H25] 1 stx1a – γ1 + − – – – 342 –
O145:[H25] 1 stx1a stx2a γ1 + − – – – 342 –
O145:[H25] 2 – stx2a γ1 + – – – – 342 –
O145:[H25] 1 – stx2a/stx2c γ1 + + – – – 342 –
O146:[H2] 1 stx1c – – + + subAB2-1/
subAB2-2
– – 442 –
O146:[H21] 1 stx1c – – – + subAB2-1/
subAB2-2
– – 442 –
O146:[H21] 1 stx1c stx2b – + + subAB2-1/
subAB2-2
– – 442 –
O146:[H28] 1 stx2b – + – subAB2-1/
subAB2-3
– – 738 –
O146:[H28] 3 stx2b – – + subAB2-2 – – 738 –
O146:[H28] 1 stx2b – – + subAB2-3 – – 738 –
O156:[H25] 1 stx1a – ζ + – – – – 4942 –
O156:[H25] 1 stx1a – nt + – – – – 5343 –
O157:[H7] 1 stx1a – γ1 + + – – – 11 11
O157:[H7] 2 stx1a stx2a γ1 + + – – – 11 11
O157:[H7] 4 stx1a stx2c γ1 + + – – – 11 11
O157:[H7] 4 – stx2a γ1 + + – – – 11 11
O157:[H7] 5 – stx2a/stx2c γ1 + + – – – 11 11
O157:[H7] 2 – stx2c γ1 + + – – – 11 11
(Continued)
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TABLE 1 | Continued
Serotypea No. of
strains
stx1 stx2 eae hlyA iha subAB aggR elt,
estIa/Ib
ST CC
O165:[H25] 1 – stx2a/stx2c ε1 + – – – – 119 –
O166:[H28] 1 stx1c – – + + subAB2-2 – – 1819 –
O174:[H28] 1 stx1c – – – + subAB2-1 – – 13 13
O174:[Hnt] 1 stx1a stx2d – + + – – – 661 –
O174:[H21] 1 – stx2c – – + – – – 677 –
O177:[H7] 1 stx1a – – – + – – – 504 –
O178:[H19] 1 – stx2c – – + – – – 192 –
O183:[Hnt] 1 stx1a stx2a – + + – – – 657 –
ONT:[H21] 1 stx1c – – + + subAB2-1/
subAB2-2
– – 737 –
ONT:[Hnt] 1 – stx2a – – – – – – 10 10
ONT:[H7] 1 – stx2b – – + subAB2-2 – – 415 59
O rough:[Hnt] 1 stx1c – – + + subAB2-1/
subAB2-2
– – 278 –
aH types determined by PCR are denoted in square brackets ([H]).
aggR gene, encoding transcriptional regulator in enteroaggregative E. coli; CC, clonal complex; eae, intimin gene; elt and estIa/Ib genes, encoding heat-labile and heat stabile enterotoxins
in enterotoxigenic E. coli; hlyA, hemolysin gene; iha, encoding iron-regulated adhesin gene; nt, not typable; ST, sequence type; stx, Shiga toxin gene (and subtypes); STEC, Shiga
toxin-producing Escherichia coli; subAB, subtilase cytotoxin gene (and subtypes); +, the gene is present; –, the gene is absent; -, not applicable.
2000–2009 in Switzerland, O26:H11, O103:H2, O121:H19, and
O145:H28/H−), respectively (Käppeli et al., 2011a). Compared
with the previous study period, infections due to STEC
O121:[H19] decreased (from 6.2 to 1.3% of all non-O157 STEC
infections), while those accounted for by STEC O146:H2/21
and STEC O146:H28 increased (from 0 to 3.9%, and 1 to
5.2%, respectively) during 2010–2014. Evaluation of the virulent
characteristics of the STEC serotypes showed that the majority
of the common serogroups O157, O145, and O26 harbored
stx2a alone or in combination with stx1 or stx2c, and showed
a consistent eae and hlyA gene pattern as described previously
(Käppeli et al., 2011a,b).
Intimin γ1 was detected most frequently in this study and was
associated with the most frequent STEC strains O157:[H7| and
O145:[H28/[H25], in agreement with previous observations for
STEC from humans (Beutin et al., 2004). Similarly, intimin β1
was found predominantly in STEC O26:[H11] and intimin ε1
in O103:[H2] and O121:[H19] (Beutin et al., 2004). Notably, the
rare intimin variant ξ was associated with serotype O80:[H2].
Of the five most common serogroups found in this study,
STEC O146 was the only serogroup that lacked the eae gene,
but contained subAB genes. Subtilase cytotoxin SubAB is an
emerging pathogenic factor that it is not routinely searched for
in isolates from patients with STEC infections. Among the 95
isolates analyzed in this study, 67.9% of the eae negative strains
harbored one or more subAB subtypes, including the recently
described subAB2-3 (Nüesch-Inderbinen et al., 2015) and 42.1%
of all subAB-positive strains were STEC O146. Whereas subAB1,
subAB2-1, and subAB2-2 have been detected in clinical isolates
elsewhere (Paton et al., 2004; Khaitan et al., 2007; Hoang Minh
et al., 2015; Son et al., 2015), this is to our knowledge the only
human clinical isolate harboring subAB2-3 described so far. Its
genome sequence is available under GenBank accession number
MPGQ00000000 (Tasara et al., 2017). Our results indicate that
the presence of subAB among STEC associated with human
disease may be currently underestimated. However, this study
was limited by the lack of anamnestic data to allow a correlation
of the presence of SubAB with severity of disease.
The five most common serogroups in this study belonged to
a limited number of CC and ST, whereas the vast majority of the
remaining STEC strains were represented by a total of 28 STs, 24
of which contained only a single isolate. CC11 comprised all the
O157 STEC, including the SF strains, confirming high clonality of
this serogroup as described previously (Bielaszewska et al., 2007;
Kossow et al., 2016). Furthermore, this CC included an isolate
belonging to O55, which is in accordance to its evolutionary
relatedness to O157 (Bono et al., 2012).
CC20 included all the O103 STEC analyzed in this study,
indicating a monophyletic origin of these strains. MLST further
demonstrated that O103 and O51 clustered together in CC20,
suggesting clonal relationship of these isolates.
Within CC29, only one of the isolates was O26:[H11]-ST29.
STEC O26:[H11] belonging to this particular ST and harboring
stx1a/stx2a or stx2a alone has been described as a virulent clone
that emerged in Germany and has been circulating in Europe
since the mid-1990ies (Bielaszewska et al., 2013).Whereas during
2000–2009, O26:H11-ST29 harboring stx1a/stx2a or stx2a alone
was detected in 11.3% of human infections due to STEC in
Switzerland (Käppeli et al., 2011a; Zweifel et al., 2013), in the
time span 2000–2014 only one such strain (1.1% of all isolates)
was isolated, suggesting a decline of the highly virulent German
clone in Switzerland over the last decade. On the other hand,
the percentage of STEC O26:[H11]-ST21, which during 2000
and 2009 accounted for 57.1% of the STEC O26 infections,
increased to 90% for the time span under observation. This
phenomenon has public health relevance, since all (100%) of
the STEC O26:[H11]-ST21 harbored stx1a, which is associated
with milder course of disease. Multilocus sequence typing further
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revealed that isolates of O26, O111, and O118 clustered together
in the same CC, indicating close relationship of these serogroups,
as established previously (Ju et al., 2012; DebRoy et al., 2016).
CC32 contained seven isolates of the serogroup O145 ST32.
In contrast, five further O145 isolates were ST342, which differs
in its allelic profile in all loci from ST32. This indicates that
the STEC O145 isolates originate from different clonal sources.
Isolates belonging to STEC O146 fell into two major STs (442
and 738, respectively), neither of which were allocated to a
particular CC.
Finally, 6.3% of the isolates analyzed in this study typed
O80:[H2]-ST301 and clustered within CC165. All these isolates
(100%) harbored stx2 (stx2a or stx2d), eae-ξ, and hlyA, 66.7%
harbored iha, and 83.3% carried 7 or more pS88 related genes,
revealing the potential of this serogroup as an etiological agent
of severe infections. O80 is a serogroup that is difficult to
type and may have gone under-detected and under-reported
so far. Recently, however, O80:H2-ST301-ξ has been reported
associated with HUS and bacteremia in France (Soysal et al.,
2016). Further studies are warranted to elucidate the reservoirs
and transmission routes of this unusual STEC.
CONCLUSIONS
We describe a collection of 95 clinical STEC strains based on
O and H serotyping, multilocus sequence typing and molecular
subtyping of virulence genes, including stx and eae subtyping
and screening for subAB variants. STEC isolated during
2010–2014 were distinguished by the presence of O157:[H7|-
ST11-γ1, O145:[H28/[H25]-ST32/ST342-γ1, O26:[H11]-ST21-
β1, O103:[H2]-ST20-ε1, and eae-negative O146:[H2/H28]-
ST442/ST738 harboring subAB variants. Furthermore, we suggest
that O80:[H2]ST-301-ξ, an STEC that possesses a rare intimin
variant and a high extraintestinal virulence potential due to
the presence of plasmid pS88-associated genes is emerging in
Switzerland. Continued efforts are required to elucidate the
origins and dissemination of this unusual STEC.
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